Literature DB >> 15219938

Elevated insulin receptor protein expression in experimentally induced colonic tumors.

Gacheri A Kiunga1, Jayadev Raju, Natasa Sabljic, Gagan Bajaj, Carolyn K Good, Ranjana P Bird.   

Abstract

Insulin is associated with augmented colon carcinogenesis in vivo, but the mechanism(s) of growth promotion is not known. This study investigates the expression profile of a key component of the insulin signaling pathway, the insulin receptor (IR), in colonic tumors in comparison to normal colonic mucosa and the effects of dietary lipids. Male F344 rats harboring preneoplastic lesions were randomly allocated to three high fat diet groups: beef tallow (HFB), corn oil (HFC), fish oil (HFF) or a low fat corn oil (LFC) diet for 16 weeks. Colonic tumors and mucosae were analyzed for IR protein by Western blot and immunohistochemical analyses. IR mRNA expression was also analyzed by semi-quantitative RT-PCR. Western blot analysis demonstrated that IR protein level was significantly greater (P < or =0.001) in tumors than in normal-appearing mucosae in each diet group, and varied (P < or =0.001) among the tumors in the order HFF>LFC>HFB>HFC. Immunohistochemical assessment of the tumors as compared to the normal mucosa confirmed the elevated expression of IR protein in the tumor cells compared to normal mucosae. Immunoreactivity was noted in the nuclear compartment. In normal colonic mucosae, IR protein levels were lower (P < or =0.001) in the saturated fat diet group (HFB) than the three unsaturated fat diet groups (LFC, HFC and HFF). IR mRNA transcript levels did not differ between colonic tumors and mucosae, and no significant diet effect was observed. These results demonstrate that steady state levels of IR are elevated in colonic tumors above that of normal mucosae in vivo irrespective of the dietary lipid environment. However, the IR mRNA transcript levels did not reflect any significant diet effect and remained relatively steady between the tumor and normal mucosa, indicating altered post transcriptional regulation of IR in tumor tissues compared to normal mucosae.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15219938     DOI: 10.1016/j.canlet.2004.02.015

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  11 in total

1.  An exon variant in insulin receptor gene is associated with susceptibility to colorectal cancer in women.

Authors:  Touraj Mahmoudi; Keivan Majidzadeh-A; Khatoon Karimi; Negar Karimi; Hamid Farahani; Reza Dabiri; Hossein Nobakht; Hesamodin Dolatmoradi; Maral Arkani; Mohammad Reza Zali
Journal:  Tumour Biol       Date:  2015-01-05

2.  Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women.

Authors:  Marc J Gunter; Donald R Hoover; Herbert Yu; Sylvia Wassertheil-Smoller; Thomas E Rohan; JoAnn E Manson; Barbara V Howard; Judith Wylie-Rosett; Garnet L Anderson; Gloria Y F Ho; Robert C Kaplan; Jixin Li; Xiaonan Xue; Tiffany G Harris; Robert D Burk; Howard D Strickler
Journal:  Cancer Res       Date:  2008-01-01       Impact factor: 12.701

3.  Methylation patterns of Vegfb promoter are associated with gene and protein expression levels: the effects of dietary fatty acids.

Authors:  Roberto Monastero; Sara García-Serrano; Ana Lago-Sampedro; Francisca Rodríguez-Pacheco; Natalia Colomo; Sonsoles Morcillo; Gracia M Martín-Nuñez; Juan M Gomez-Zumaquero; Eduardo García-Fuentes; Federico Soriguer; Gemma Rojo-Martínez; Eva García-Escobar
Journal:  Eur J Nutr       Date:  2015-12-26       Impact factor: 5.614

Review 4.  The Association between Polymorphismsin Insulin and Obesity Related Genesand Risk of Colorectal Cancer.

Authors:  Mostafa Rezaei-Tavirani; Akram Safaei; Mohammad Reza Zali
Journal:  Iran J Cancer Prev       Date:  2013

5.  A Prospective Investigation of Body Size, Body Fat Composition and Colorectal Cancer Risk in the UK Biobank.

Authors:  Luisa Saldana Ortega; Kathryn E Bradbury; Amanda J Cross; Jessica S Morris; Marc J Gunter; Neil Murphy
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

6.  Associations Between Glycemic Traits and Colorectal Cancer: A Mendelian Randomization Analysis.

Authors:  Neil Murphy; Mingyang Song; Nikos Papadimitriou; Robert Carreras-Torres; Claudia Langenberg; Richard M Martin; Konstantinos K Tsilidis; Inês Barroso; Ji Chen; Timothy M Frayling; Caroline J Bull; Emma E Vincent; Michelle Cotterchio; Stephen B Gruber; Rish K Pai; Polly A Newcomb; Aurora Perez-Cornago; Franzel J B van Duijnhoven; Bethany Van Guelpen; Pavel Vodicka; Alicja Wolk; Anna H Wu; Ulrike Peters; Andrew T Chan; Marc J Gunter
Journal:  J Natl Cancer Inst       Date:  2022-05-09       Impact factor: 11.816

7.  Diabetes Mellitus and Site-specific Colorectal Cancer Risk in Korea: A Case-control Study.

Authors:  Hyeongtaek Woo; Jeeyoo Lee; Jeonghee Lee; Ji Won Park; Sungchan Park; Jeongseon Kim; Jae Hwan Oh; Aesun Shin
Journal:  J Prev Med Public Health       Date:  2016-01

8.  Fasting glucose and risk of colorectal cancer in the Korean Multi-center Cancer Cohort.

Authors:  Hyeree Park; Sooyoung Cho; Hyeongtaek Woo; Sue K Park; Hai-Rim Shin; Soung-Hoon Chang; Keun-Young Yoo; Aesun Shin
Journal:  PLoS One       Date:  2017-11-21       Impact factor: 3.240

9.  Colorectal Cancer Risks According to Sex Differences in Patients With Type II Diabetes Mellitus: A Korean Nationwide Population-Based Cohort Study.

Authors:  Ji Min Lee; Kang-Moon Lee; Dae Bum Kim; Seung-Hyun Ko; Yong Gyu Park
Journal:  Clin Transl Gastroenterol       Date:  2019-10       Impact factor: 4.488

10.  Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study.

Authors:  Caroline J Bull; Joshua A Bell; Neil Murphy; Eleanor Sanderson; George Davey Smith; Nicholas J Timpson; Barbara L Banbury; Demetrius Albanes; Sonja I Berndt; Stéphane Bézieau; D Timothy Bishop; Hermann Brenner; Daniel D Buchanan; Andrea Burnett-Hartman; Graham Casey; Sergi Castellví-Bel; Andrew T Chan; Jenny Chang-Claude; Amanda J Cross; Albert de la Chapelle; Jane C Figueiredo; Steven J Gallinger; Susan M Gapstur; Graham G Giles; Stephen B Gruber; Andrea Gsur; Jochen Hampe; Heather Hampel; Tabitha A Harrison; Michael Hoffmeister; Li Hsu; Wen-Yi Huang; Jeroen R Huyghe; Mark A Jenkins; Corinne E Joshu; Temitope O Keku; Tilman Kühn; Sun-Seog Kweon; Loic Le Marchand; Christopher I Li; Li Li; Annika Lindblom; Vicente Martín; Anne M May; Roger L Milne; Victor Moreno; Polly A Newcomb; Kenneth Offit; Shuji Ogino; Amanda I Phipps; Elizabeth A Platz; John D Potter; Conghui Qu; J Ramón Quirós; Gad Rennert; Elio Riboli; Lori C Sakoda; Clemens Schafmayer; Robert E Schoen; Martha L Slattery; Catherine M Tangen; Kostas K Tsilidis; Cornelia M Ulrich; Fränzel J B van Duijnhoven; Bethany van Guelpen; Kala Visvanathan; Pavel Vodicka; Ludmila Vodickova; Hansong Wang; Emily White; Alicja Wolk; Michael O Woods; Anna H Wu; Peter T Campbell; Wei Zheng; Ulrike Peters; Emma E Vincent; Marc J Gunter
Journal:  BMC Med       Date:  2020-12-17       Impact factor: 11.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.